Ensysce Biosciences, Inc.
ENSC
$0.25
$0.000.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.77M | -3.73M | -1.73M | -1.95M | -3.56M |
| Total Depreciation and Amortization | 6.50K | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 0.00 |
| Total Other Non-Cash Items | 442.10K | 98.70K | 251.40K | 55.40K | 47.80K |
| Change in Net Operating Assets | 793.20K | 1.76M | -1.22M | 182.80K | 2.75M |
| Cash from Operations | -1.53M | -1.87M | -2.71M | -1.71M | -764.10K |
| Capital Expenditure | 0.00 | -123.60K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -123.60K | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -105.00K | -40.00K | -24.10K | -47.20K | -96.30K |
| Issuance of Common Stock | 684.40K | 1.50M | 42.90K | 1.45M | 357.90K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 3.98M | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -391.40K | -5.40K | 1.85M | -143.00K | -149.00K |
| Cash from Financing | 4.16M | 1.45M | 1.87M | 1.26M | 112.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.64M | -538.40K | -840.90K | -449.60K | -651.50K |